Inhibikase Therapeutics reported raising $4.2 Million in an initial SEC Form D filing, from an offering of $4.2 Million
Round Type
Seed
AtlantaBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalQuick answer
Inhibikase Therapeutics raised $4.2 Million in a Seed round, dated January 27, 2023. Inhibikase Therapeutics is based in Atlanta, Georgia, United States.
- How much did Inhibikase Therapeutics raise?
- Inhibikase Therapeutics raised $4.2 Million in a Seed round on January 27, 2023.
- What does Inhibikase Therapeutics do?
- Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson's-related disorders and other..
- Where is Inhibikase Therapeutics based and how big is it?
- Inhibikase Therapeutics is based in Atlanta, Georgia, United States.
- Who are the decision-makers at Inhibikase Therapeutics?
- Fundz holds 4 contacts at Inhibikase Therapeutics, including the President, Head of Research and Development, Chief Medical Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as Inhibikase Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Azora Therapeutics, Inc. (DE) raised $62K (Pre-Seed) on February 23, 2023.
- Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
- QurAlis raised $88M (Series B) on March 9, 2023.
- Tessera Defense & Homeland Security Inc. raised $1.5M (Seed) on February 27, 2023.
- Pathos AI raised $20M on February 17, 2023.
- Disc raised $63M (Funding Round) on February 14, 2023.
Who to call at Inhibikase Therapeutics, and when
A new round usually means Inhibikase Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Inhibikase Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Inhibikase Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Inhibikase Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Inhibikase Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Inhibikase Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.